RHHVF
Price
$319.10
Change
-$2.43 (-0.76%)
Updated
Sep 26 closing price
Capitalization
255.57B
26 days until earnings call
SNPHY
Price
$10.95
Change
+$0.20 (+1.86%)
Updated
Sep 26 closing price
Capitalization
3.6B
Interact to see
Advertisement

RHHVF vs SNPHY

Header iconRHHVF vs SNPHY Comparison
Open Charts RHHVF vs SNPHYBanner chart's image
Roche Holding
Price$319.10
Change-$2.43 (-0.76%)
Volume$576
Capitalization255.57B
Santen Pharmaceutical
Price$10.95
Change+$0.20 (+1.86%)
Volume$3.76K
Capitalization3.6B
RHHVF vs SNPHY Comparison Chart in %
Loading...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHVF vs. SNPHY commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHVF is a Hold and SNPHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (RHHVF: $319.10 vs. SNPHY: $10.95)
Brand notoriety: RHHVF and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHVF: 6% vs. SNPHY: 83%
Market capitalization -- RHHVF: $255.57B vs. SNPHY: $3.6B
RHHVF [@Pharmaceuticals: Major] is valued at $255.57B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHVF’s FA Score shows that 1 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).

  • RHHVF’s FA Score: 1 green, 4 red.
  • SNPHY’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHVF is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHVF’s TA Score shows that 4 TA indicator(s) are bullish while SNPHY’s TA Score has 5 bullish TA indicator(s).

  • RHHVF’s TA Score: 4 bullish, 6 bearish.
  • SNPHY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNPHY is a better buy in the short-term than RHHVF.

Price Growth

RHHVF (@Pharmaceuticals: Major) experienced а -5.22% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was -2.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.20%. For the same industry, the average monthly price growth was -0.44%, and the average quarterly price growth was +12.50%.

Reported Earning Dates

RHHVF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.20% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($256B) has a higher market cap than SNPHY($3.6B). RHHVF has higher P/E ratio than SNPHY: RHHVF (21.60) vs SNPHY (15.71). RHHVF YTD gains are higher at: 13.964 vs. SNPHY (8.202). SNPHY has higher annual earnings (EBITDA): 51.1B vs. RHHVF (18B). SNPHY has more cash in the bank: 85.9B vs. RHHVF (12B). SNPHY has higher revenues than RHHVF: SNPHY (303B) vs RHHVF (63.5B).
RHHVFSNPHYRHHVF / SNPHY
Capitalization256B3.6B7,109%
EBITDA18B51.1B35%
Gain YTD13.9648.202170%
P/E Ratio21.6015.71138%
Revenue63.5B303B21%
Total Cash12B85.9B14%
Total Debt33BN/A-
FUNDAMENTALS RATINGS
RHHVF vs SNPHY: Fundamental Ratings
RHHVF
SNPHY
OUTLOOK RATING
1..100
6426
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5957
P/E GROWTH RATING
1..100
4085
SEASONALITY SCORE
1..100
n/a9

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (12) in the null industry is in the same range as SNPHY (34). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHVF's Profit vs Risk Rating (100) in the null industry is in the same range as SNPHY (100). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHVF's SMR Rating (99) in the null industry is in the same range as SNPHY (100). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

SNPHY's Price Growth Rating (57) in the null industry is in the same range as RHHVF (59). This means that SNPHY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHVF's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for SNPHY (85). This means that RHHVF’s stock grew somewhat faster than SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHVFSNPHY
RSI
ODDS (%)
Bearish Trend 3 days ago
54%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 7 days ago
52%
Bullish Trend 5 days ago
54%
Declines
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 11 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
37%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWEVF2.570.04
+1.58%
Alphawave IP Group PLC
TNREF0.19N/A
+1.14%
Taranis Resources Inc.
DLMI4.94N/A
N/A
Diamond Lake Minerals, Inc.
ZLSUF1.00N/A
N/A
Zalatoris II Acquisition Corp.
DPMAY282.08-1.49
-0.53%
Diploma Plc.

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-0.76%
RHHBY - RHHVF
66%
Loosely correlated
-0.93%
RHHBF - RHHVF
29%
Poorly correlated
+1.51%
OTSKY - RHHVF
14%
Poorly correlated
-2.51%
SNPHY - RHHVF
7%
Poorly correlated
+1.86%
SNPHF - RHHVF
4%
Poorly correlated
N/A
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and SNPHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
+1.86%
SNPHF - SNPHY
7%
Poorly correlated
N/A
RHHVF - SNPHY
7%
Poorly correlated
-0.76%
RHHBF - SNPHY
6%
Poorly correlated
+1.51%
RHHBY - SNPHY
5%
Poorly correlated
-0.93%
OTSKY - SNPHY
4%
Poorly correlated
-2.51%
More